A Day Up For PainReform Ltd.
Thu, Dec 05, 2024 at 07:33 PM
PainReform Ltd. (PRFX:NASDAQ) shot up at $4.5, representing a gain of 67.9%. On Thu, Dec 05, 2024, PRFX:NASDAQ hit a New 2-Week High of $4.5. The stock appeared on our News Catalysts scanner on Wed, Nov 20, 2024 at 12:08 PM in the 'BIOTECH' category. From Thu, Nov 21, 2024, the stock recorded 44.44% Up Days and 50.00% Green Days
The stock spiked on Thu, Dec 05, 2024 at $5.84 with a volume of 33M+.
About PainReform Ltd. (PRFX:NASDAQ)
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics.
Top 10 Gainers:
- Oriental Rise Holdings Limited (ORIS:NASDAQ), 599.25%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 93.95%
- ArTara Therapeutics, Inc. (TARA:NASDAQ), 70.06%
- PainReform Ltd. (PRFX:NASDAQ), 67.91%
- CalAmp Corp. (CAMP:NASDAQ), 65.99%
- Molecular Templates, Inc. (MTEM:NASDAQ), 60.26%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 59.38%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 56.05%
- Foxx Development Holdings Inc. (FOXX:NASDAQ), 54.69%
- SRIVARU Holding Limited (SVMH:NASDAQ), 48.94%